• Skip to main content

Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

  • How To Publish
  • How to Write Plain Language Summaries
  • Frequently Asked Questions
  • Publications
    • Animated Videos
    • Bladder, Kidney and Genitals
    • Brain and Nerves
    • Cancer
    • Diabetes and Metabolic Hormones
    • Eyes and Vision
    • Heart and Circulation
    • Infections
    • Inflammatory and Immune-related disorders
    • Mental Health
    • Muscle and Bone
    • Rare Diseases
    • Skin
    • Vaccines
  • Advisory Panel
  • Supporters
  • Blog
  • About Us
  • Contact Us

Jun 10 2021

Plain language summary of the final results from the GioTag study

The latest PLSP published in Future Oncology provides a summary of the GioTag study, that looked at how the drugs afatinib and osimertinib affected people with non-small cell lung cancer (NSCLC) who had mutations in the epidermal growth factor receptor (EGFR) gene. The PLSP, written by Professor Maximilian J Hochmair, is a summary of the final analysis of the GioTag study published in Future Oncology last year.

By publishing both the original article and PLSP is the same journal, we are able to link the publications to make readers of either article aware of the original and PLS versions.

Read the article in full here.

The original article, entitled ‘Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: final analysis of the GioTag study’, published in Future Oncology, can be found here.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Joanne Walker · Categorized: Cancer · Tagged: Afatinib, EGFR, epidermal growth factor receptor, non-small cell lung, osimertinib

Copyright © 2023 · Plain Language Summaries · Terms and Conditions · Privacy Policy ·